NCT04939922 China Headache and Vertigo Registry Study
| NCT ID | NCT04939922 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Condition | Headache Disorders, Primary |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2017-06-12 |
| Primary Completion | 2050-12-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2017-06-12 with a primary completion date of 2050-12-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In the Chinese Headache and Vertigo Registration Study, patients aged 4-99 years with headache (primary headache and secondary headache such as migraine and tension type headache), vertigo (vertigo diseases such as vestibular migraine) and chronic pain (fibromyalgia and other diseases) were collected. The biomarkers, imaging features, right-to-left shunt of the heart (lung), genetic characteristics, treatment, and outcome (in relation to other diseases) of headache-related diseases were studied, and long-term follow-up was planned.
Eligibility Criteria
Inclusion Criteria: * Written informed consent and participant privacy information (eg, Written Authorization for Use and Release of Health and Research Study Information) obtained from the participant prior to initiation of any study-specific procedures. * Male or female participants ages 4 to 99 years. * Headache patients meeting the diagnostic criteria for ICHD-3, including primary headaches such as migraine and tension tension-type headaches, secondary headaches. * Patients who meet the headache diagnosis in the ICHD-3 appendix (including vestibular migraine). Exclusion Criteria: * Patients who were unable to complete scales such as headache diary. * Patients denied or unable to be admitted for long-term follow-up.
Contact & Investigator
Kaiming Liu, Doctor
PRINCIPAL INVESTIGATOR
headache specialist clinic of the Second Affiliated Hospital of Zhejiang Medical University
Frequently Asked Questions
Who can join the NCT04939922 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 99 Years, studying Headache Disorders, Primary. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04939922 currently recruiting?
Yes, NCT04939922 is actively recruiting participants. Contact the research team at 2314411@zju.edu.cn for enrollment information.
Where is the NCT04939922 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT04939922 clinical trial?
NCT04939922 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. The principal investigator is Kaiming Liu, Doctor at headache specialist clinic of the Second Affiliated Hospital of Zhejiang Medical University. The trial plans to enroll 10,000 participants.